⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for prostaglandin e2 (pge2)

Every month we try and update this database with for prostaglandin e2 (pge2) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid TumorsNCT04344795
Solid Tumor
Colorectal Canc...
Non Small Cell ...
Squamous Cell C...
Urothelial Carc...
Endometrial Can...
Gastroesophagea...
Gastric Adenoca...
Solid Tumors Wi...
TPST-1495 twice...
TPST-1495 once ...
Pembrolizumab
18 Years - Tempest Therapeutics
A Phase Ib/IIa Study of CR6086 in Combination With Balstilimab in pMMR-MSS Metastatic Colorectal Cancer PatientsNCT05205330
Refractory Meta...
Solid Tumor
Metastatic Micr...
Mismatch Repair...
CR6086
AGEN2034
18 Years - Rottapharm Biotech
Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid TumorsNCT04344795
Solid Tumor
Colorectal Canc...
Non Small Cell ...
Squamous Cell C...
Urothelial Carc...
Endometrial Can...
Gastroesophagea...
Gastric Adenoca...
Solid Tumors Wi...
TPST-1495 twice...
TPST-1495 once ...
Pembrolizumab
18 Years - Tempest Therapeutics
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: